View in EDS HTML Full Text PDF Full Text

ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors.

Saved in:
Bibliographic Details
Title: ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors.
Authors: Shin, Seol Hwa1,2,3 (AUTHOR), Ju, Eun Jin1,2,3 (AUTHOR), Park, Jin1,2,3 (AUTHOR), Ko, Eun Jung1,2,3 (AUTHOR), Kwon, Mi Ri1,2,3 (AUTHOR), Lee, Hye Won1,2,3 (AUTHOR), Son, Ga Won1,2,3 (AUTHOR), Park, Yun-Yong4 (AUTHOR), Kim, Yeon Joo5 (AUTHOR), Song, Si Yeol5 (AUTHOR), Lee, Sangkwang6 (AUTHOR), Seo, Beom Seok6 (AUTHOR), Song, Jin-A6 (AUTHOR), Lim, Sangbin6 (AUTHOR), Jung, Doohwan6 (AUTHOR), Kim, Sunyoung6 (AUTHOR), Lee, Hyangsook5 (AUTHOR), Park, Seok Soon1,2,3 (AUTHOR) pssooni@amc.seoul.kr, Jeong, Seong-Yun1,2,3 (AUTHOR) syj@amc.seoul.kr, Choi, Eun Kyung1,2,3,5 (AUTHOR) ekchoi@amc.seoul.kr
Source: Cancer Cell International. 8/18/2023, Vol. 23 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752867
DOI:10.1186/s12935-023-02991-x